LEADER 05414nam  2200685Ia 450 
001 9910455937803321
005 20200520144314.0
010   $a1-280-19573-8
010   $a9786610195732
010   $a0-309-58650-X
010   $a0-585-13756-0
035   $a(CKB)110986584751416
035   $a(EBL)3376332
035   $a(SSID)ssj0000398694
035   $a(PQKBManifestationID)12123220
035   $a(PQKBTitleCode)TC0000398694
035   $a(PQKBWorkID)10362922
035   $a(PQKB)10515807
035   $a(MiAaPQ)EBC3376332
035   $a(Au-PeEL)EBL3376332
035   $a(CaPaEBR)ebr10055460
035   $a(OCoLC)923262981
035   $a(EXLCZ)99110986584751416
100   $a19931220d1994      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aWorkshop and commissioned papers$b[electronic resource] $eethical and legal issues of including women in clinical studies /$fAnna C. Mastroianni, Ruth Faden, and Daniel Federman, editors ; Committee on the Ethical and Legal Issues Relating to the Inclusion of Women in Clinical Studies, Division of Health Sciences Policy, Institute of Medicine
210   $aWashington, D.C. $cNational Academy Press$d1994
215   $a1 online resource (264 p.)
225 0 $aWomen and health research ;$vv.2
300   $aDescription based upon print version of record.
311   $a0-309-05040-5 
320   $aIncludes bibliographical references and index.
327   $a""WOMEN AND HEALTH RESEARCH""; ""Copyright""; ""Preface""; ""Contents""; ""Women's Participation in Clinical Research: From Protectionism to Access""; ""CURRENT FEDERAL POLICY""; ""PROTECTIONIST POLICIES""; ""ADVENT OF INCLUSIONARY POLICIES""; ""CONCLUSION""; ""NOTES""; ""Women in Clinical Studies: A Feminist View""; ""NOTES""; ""Ethical Issues Related to the Inclusion of Pregnant Women in Clinical Trials (I)""; ""THE PREGNANT WOMAN AS SUBJECT""; ""Therapeutic: To Meet the Health Needs of the Mother""; ""Nontherapeutic Research: Not Meeting the Health Needs of the Pregnant Woman""
327   $a""THE FETUS AS SUBJECT""""Therapeutic: To Meet the Health Needs of the Fetus""; ""Nontherapeutic Fetal Research: Not to Meet the Fetus's Health Needs""; ""NOTES""; ""Ethical Issues Related to the Inclusion of Pregnant Women in Clinical Trials (II)""; ""REFERENCES""; ""Ethical Issues Related to the Inclusion of Women of Childbearing Age in Clinical Trials""; ""NOTES""; ""Health Consequences of Exclusion or Underrepresentation of Women in Clinical Studies (I)""; ""TYPES OF INFORMATION DEFICITS""; ""TYPES OF CONSEQUENCES""; ""Morbidity and Mortality""; ""Diagnosis and Treatment Patterns""
327   $a""Treatment Outcomes""""Provider Perceptions""; ""CONCLUSIONS""; ""NOTES""; ""Health Consequences of Exclusion or Underrepresentation of Women in Clinical Studies (II)""; ""Recruitment and Retention of Women in Clinical Studies: Theoretical Perspectives and Methodological Considerations""; ""THE DYNAMICS OF RECRUITMENT AND RETENTION""; ""CROSS-CULTURAL DIFFERENCES: MEN VS. WOMEN""; ""GENDER DIFFERENCES: IMPLICATIONS FOR RESEARCH""; ""METHODOLOGICAL CONSIDERATIONS FOR RESEARCHERS""; ""REFERENCES""; ""Recruitment and Retention of Women of Color in Clinical Studies""; ""NOTES""
327   $a""Recruitment and Retention of Women in Clinical Studies: Ethical Considerations""""INCENTIVES TO ENROLL AND TO CONTINUE PARTICIPATION""; ""FREE ABORTION AS AN INCENTIVE""; ""DEALING WITH DROPOUTS""; ""COSTS OF INVOLVING WOMEN AS RESEARCH SUBJECTS""; ""TWO SEPARATE AGENDAS ON THE INCLUSION OF WOMEN""; ""WOMEN IN (SOME) DEVELOPING COUNTRIES""; ""REFERENCES""; ""Impact of Current Federal Regulations on the Inclusion of Female Subjects in Clinical Studies""; ""THE IMPACT OF PRESENT LAW""; ""Regulations that Appear to Limit Women's Participation in Clinical Research""
327   $a""FDA Definition of ""Childbearing Potential"" and Required Prior Reproductive Studies""""DHHS Limitations on Research with Pregnant Women""; ""Federal Requirements that Support the Inclusion of Women in Clinical Research""; ""FDA Premarketing Testing""; ""DHHS Regulations on Research with Children""; ""RECOMMENDED CHANGES IN THE FEDERAL LAW""; ""Amendment of FDA Regulations""; ""Amendment of DHHS Regulations""; ""National Institutes of Health Policy""; ""CONCLUSION""; ""NOTES""; ""Brief Overview of Constitutional Issues Raised by the Exclusion of Women from Research Trials""
327   $a""DISPARATE TREATMENT, DISPARATE BENEFITS, AND EQUAL OPPORTUNITY""
606   $aHuman experimentation in medicine$xLaw and legislation
606   $aHuman experimentation in medicine$xMoral and ethical aspects
606   $aWomen$xHealth and hygiene$xResearch$xMoral and ethical aspects
608   $aElectronic books.
615  0$aHuman experimentation in medicine$xLaw and legislation.
615  0$aHuman experimentation in medicine$xMoral and ethical aspects.
615  0$aWomen$xHealth and hygiene$xResearch$xMoral and ethical aspects.
676   $a174/.28
701   $aFaden$b Ruth R$0930475
701   $aFederman$b Daniel D.$f1928-$0930476
701   $aMastroianni$b Anna C$0930477
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910455937803321
996   $aWorkshop and commissioned papers$92092914
997   $aUNINA